Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches
- 31 March 1995
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 9 (1) , 33-45
- https://doi.org/10.1016/0268-960x(95)90038-1
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Lactic acid bacteria and human clinical infectionJournal of Applied Bacteriology, 1993
- Iron depletion: A defense against intracellular infection and neoplasiaLife Sciences, 1992
- Design, Properties, and Effective Use of the Oral Chelator L1 and OtherAnnals of the New York Academy of Sciences, 1990
- Deferoxamine-induced growth retardation in patients with thalassemia majorThe Journal of Pediatrics, 1988
- The effect of synthetic iron chelators on bacterial growth in human serumFEMS Microbiology Letters, 1988
- Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K‐562 and U‐937 cell lines induced by chelators and their iron complexesEuropean Journal of Haematology, 1987
- Orally Active Alpha-Ketohydroxypyridine Iron Chelators: Effects on Iron and Other Metal MobilisationsActa Haematologica, 1987
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- The study of iron mobilisation from transferrin using α-ketohydroxy heteroaromatic chelatorsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Iron depletion: Possible cause of tumor cell cytotoxicity induced by activated macrophagesBiochemical and Biophysical Research Communications, 1984